Gastrointestinal endoscopy was born almost 40 years ago as diagnostic modality, but in last two decades with gradually developing of therapeutic possibilities gastroenterologists have taken an increasing role in the iinterventional treatment of many upper gastrointestinal problems. Modalities of treatment for esophageal stenoses were explained. Endoscopists should be aware that all of these methods has their limitations and they must be able to balance technological enthusiasm with full consideration of the patients qualities of life. All of this treatments are palliative, risky and only partially effective at best. They often need to be repeated. Even achieving a large lumen will not restore normal swallowing. The goal must be to restore "adequate but not perfect" swallowing, at lowest risk, cost and inconvenience to the patient.

Download full-text PDF

Source

Publication Analysis

Top Keywords

endoscopic treatment
4
treatment benign
4
benign malignant
4
malignant esophageal
4
esophageal stenosis
4
stenosis gastrointestinal
4
gastrointestinal endoscopy
4
endoscopy born
4
born years
4
years ago
4

Similar Publications

Giant ovarian cysts (GOCs) have become less common in developed countries due to routine health screenings, but they remain prevalent in economically underdeveloped regions. Treatment options for GOCs depend on factors such as age, cyst characteristics, and pregnancy status. Minimally invasive single-port laparoscopic surgery has largely replaced traditional open surgery due to its aesthetic advantages and effectiveness.

View Article and Find Full Text PDF

Vedolizumab (VDZ) is approved in the treatment of patients with moderate to severe ulcerative colitis (UC) or Crohn's disease (CD). VDZ exhibits considerable variability in its pharmacokinetic (PK) profile, and its exposure-response relationship is not yet fully understood. The aim was to investigate the variability in VDZ trough levels and PK parameters, to assess the relationship between VDZ PK and biochemical response, as well as clinical and endoscopic outcomes.

View Article and Find Full Text PDF

Background: This study evaluated the long-term effectiveness and safety of a multidisciplinary early proactive therapeutic drug monitoring (TDM) program combined with Bayesian forecasting for infliximab (IFX) dose adjustment in a real-world dataset of paediatric patients with inflammatory bowel disease (IBD).

Methods: A descriptive, ambispective, single-centre study of paediatric patients with IBD who underwent IFX serum concentration measurements between September 2015 and September 2023. The patients received reactive TDM before September 2019 (n = 17) and proactive TDM thereafter (n = 21).

View Article and Find Full Text PDF

Micronutrient deficiencies (MNDs) are commonly reported after bariatric and metabolic surgery, including laparoscopic sleeve gastrectomy (LSG). Nevertheless, the micronutrient status changes over time and the influence of sex or initial body mass index (BMI) on these changes are less explored. This study aims to investigate the changes in micronutrient levels at 6 and 12 months after LSG and the potential influence of sex or baseline BMI (≥40 kg/m) on these changes in patients submitted to LSG.

View Article and Find Full Text PDF

Tacrine is a centrally active non-competitive reversible acetylcholinesterase inhibitor. It also exerts antagonising activity against -methyl-D-aspartate receptors. Tacrine was approved for the treatment of Alzheimer's disease in 1993, but was withdrawn from clinical use in 2013 because of its hepatotoxicity and gastrointestinal side effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!